Antioxidant Supplementation in Trauma Patients

NCT ID: NCT00613392

Last Updated: 2016-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Administration of antioxidants to trauma patients will improve measures of oxidant stress in the blood

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

powdered antioxidant

Intervention Type DIETARY_SUPPLEMENT

one vial mixed with water every day orally or through enteral tube

2

Group Type PLACEBO_COMPARATOR

powdered cornstarch placebo

Intervention Type DIETARY_SUPPLEMENT

one vial mix with water and administer orally or via enteral tube

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

powdered antioxidant

one vial mixed with water every day orally or through enteral tube

Intervention Type DIETARY_SUPPLEMENT

powdered cornstarch placebo

one vial mix with water and administer orally or via enteral tube

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult non pregnant non lactating trauma patient

Exclusion Criteria

* GCS \<6
* Renal dysfunction (cre \> 2.5 mg/dl)
* Hepatic dysfunction ( TBili \> 3.0 mg/dl)
* Expected survival \< 48 hours
* Burns over \> 20% body surface area
* Immune-deficiency syndromes
* Steroid use
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Burke, MD

Role: STUDY_DIRECTOR

Boston Medical Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-25038

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multi-Nutrient Supplement for Radio-Protection
NCT04781868 UNKNOWN EARLY_PHASE1
Effect of OPC Factor on Energy Levels
NCT00318019 COMPLETED PHASE2
Trial to Assess Chelation Therapy (TACT)
NCT00044213 COMPLETED PHASE3